Background illustration for clinical trials search

Autoimmune Disorders Clinical Trials

Browse 881 autoimmune disorders clinical trials enrolling across the United States and Canada. 117 people applied to autoimmune disorders studies last month. Search by city or state to find one near you.

Filter
1
Active & Responsive

Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease

for
Graves' Disease
Location: Sayre PA, Cary NC, Miami Lakes FL, Orchard Park NY,
Sponsor: Yarrow Bioscience, Inc.

Sex: All

Age: 18+

Code: NCT07682896

Phase 2, Recruiting
Active & Responsive

Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

for
Type 1 Diabetes
Location: Portland ME, Boston MA, New York NY, Norfolk VA,
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT07676565

Recruiting
Active & Responsive

Genes and Environment in Multiple Sclerosis

for
Multiple Sclerosis
Location: New York NY, Bethesda MD, Pittsburgh PA
Sponsor: Columbia University

Sex: All

Age: 18+

Code: NCT01353547

Recruiting
Active & Responsive

Repetitive Transcranial Magnetic Stimulation (rTMS) in MS Induced Spastic Paraparesis

for
Multiple Sclerosis
Location: Gatineau
Sponsor: Clinique Neuro-Outaouais

Sex: All

Age: 18 - 70

Code: NCT07159789

Recruiting
Active & Responsive

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

for
Myotonic Dystrophy Type 1 (DM1), DM1, Myotonic Dystrophy,
Location: Baltimore MD, Richmond VA, Rochester NY, Gainesville FL,
Sponsor: Dyne Therapeutics

Sex: All

Age: 16+

Code: NCT07486934

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

for
Type I Diabetes
Location: Birmingham AL, Chicago IL, Aurora CO, Renton WA,
Sponsor: Op-T LLC

Sex: All

Age: 18 - 50

Code: NCT06964087

Phase 2, Recruiting
Active & Responsive

Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)

for
Optic Neuritis, Myelitis, Myelitis, Transverse
Location: Boston MA, North Haven CT, New York NY, Baltimore MD,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07100990

Phase 3, Recruiting
Active & Responsive

Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)

for
IgA Nephropathy (IgAN)
Location: Jacksonville FL, Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06676579

Phase 2, Recruiting
Active & Responsive

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

for
Immune Thrombocytopenic Purpura (ITP)
Location: Boston MA, The Bronx NY, New York NY, Philadelphia PA,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06722235

Phase 3, Recruiting
Active & Responsive

Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic Outcomes

for
Type 1 Diabetes
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 18+

Code: NCT06021145

Recruiting
Active & Responsive

An Adaptive Design Study of MTX228

for
Type 1 Diabetes Mellitus
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18 - 65

Code: NCT06474598

Phase 2, Recruiting
Active & Responsive

Vitaccess Real MG Registry

for
Myasthenia Gravis
Location: Lumberton NJ, Charleston SC, Lexington KY, O'Fallon IL,
Sponsor: Vitaccess Ltd

Sex: All

Age: 18+

Code: NCT06064461

Recruiting
Active & Responsive

A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)

for
Neuromyelitis Optica Spectrum Disorder, NMOSD
Location: Denver CO
Sponsor: Hoffmann-La Roche

Sex: All

Age: 2 - 11

Code: NCT05199688

Phase 3, Recruiting
Active & Responsive

Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

for
Systemic Lupus Erythematosus
Location: New York NY, Hackensack NJ, Hershey PA, Atlanta GA,
Sponsor: NYU Langone Health

Sex: All

Age: 55+

Code: NCT05799378

Phase 3, Recruiting
Active & Responsive

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

for
Relapsing Multiple Sclerosis,
Location: Worcester MA, New York NY, Philadelphia PA, Richmond VA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 55

Code: NCT04047628

Phase 3, Recruiting
Active & Responsive

Non-invasive Electrical Spinal Cord Stimulation To Restore Upper Extremity Function in Multiple Sclerosis

for
Multiple Sclerosis
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 21 - 70

Code: NCT06552611

Phase 1, Recruiting
Active & Responsive

Type 1 Diabetes Management Using a Very Low Carbohydrate Versus Standard Diet

for
Type1diabetes
Location: Boston MA
Sponsor: Boston Children's Hospital

Sex: All

Age: 18 - 40

Code: NCT03710928

Recruiting
Active & Responsive

A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis

for
Rheumatoid Arthritis (RA)
Location: Duncansville PA, Cutler Bay FL, Miami FL
Sponsor: SynAct Pharma Aps

Sex: All

Age: 18+

Code: NCT06671054

Phase 2, Recruiting
Active & Responsive

Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

for
Myasthenia Gravis, Myasthenia Gravis, MuSK
Location: Chapel Hill NC, Boca Raton FL, Tampa FL, Augusta GA,
Sponsor: NMD Pharma A/S

Sex: All

Age: 18+

Code: NCT06414954

Phase 2, Recruiting
Active & Responsive

Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes

for
Diabetes Mellitus, Type 1, Diabetes Complications
Location: Boston MA, The Bronx NY
Sponsor: Boston Medical Center

Sex: All

Age: 18 - 70+

Code: NCT06236607

Recruiting